Valtrex (valacyclovir) is one of the most widely prescribed antivirals for herpes-related conditions, and its effectiveness varies depending on what it’s being used for. For genital herpes, daily suppressive therapy reduces outbreaks by 70% to 80%. For cold sores, it shortens episodes by about a day. For shingles, it reduces pain severity and duration when started early. Here’s a closer look at what the drug actually delivers for each condition.
Why Valtrex Works Better Than Older Antivirals
Valtrex is a prodrug, meaning your body converts it into acyclovir, the same active compound found in the older antiviral Zovirax. The key difference is absorption. Oral acyclovir has a bioavailability of only 10% to 20%, meaning most of what you swallow never makes it into your bloodstream. Valacyclovir reaches about 54.5% bioavailability, roughly three to five times higher. This means you get significantly more of the active drug working in your body with fewer daily doses.
Genital Herpes: Suppressive vs. Episodic Use
Valtrex is used for genital herpes in two distinct ways, and the effectiveness profile is different for each.
Suppressive therapy means taking the medication daily to prevent outbreaks from happening in the first place. According to CDC treatment guidelines, this approach reduces the frequency of recurrences by 70% to 80% in people who experience frequent outbreaks. The standard dose for most people is one pill once a day. For those with nine or fewer outbreaks per year, a lower daily dose is also an option. Daily suppressive therapy also reduces the risk of transmitting the virus to an uninfected sexual partner, which is one of the reasons many people choose this approach even when their outbreaks are manageable.
Episodic therapy means taking Valtrex only when you feel an outbreak coming on. This approach works best when you start the medication within one day of lesion onset or during the prodrome, that early tingling or burning sensation that precedes some outbreaks. Started in this window, it shortens the duration and severity of the episode. If you wait until sores are already fully developed, the benefit drops significantly. The typical episodic course for a recurrent outbreak is three days.
For a first genital herpes episode, which tends to be longer and more severe, treatment runs for 10 days and helps reduce the overall duration and intensity of symptoms.
Cold Sores: A Modest but Real Benefit
For cold sores (oral herpes), Valtrex uses a high-dose, short-duration approach: two large doses taken 12 hours apart in a single day. You need to start at the very first sign of a cold sore, such as tingling, itching, or burning on the lip.
The results are real but modest. In clinical trials submitted to the FDA, treated subjects had cold sore episodes that lasted about one day shorter than those taking a placebo. That’s meaningful when an untreated cold sore typically lasts 7 to 10 days. However, Valtrex did not significantly prevent cold sores from progressing past the early papule stage once they had started forming. In other words, it can speed healing, but it won’t reliably stop a cold sore in its tracks once a visible bump appears. The takeaway: timing matters enormously. The earlier you take it, the more you benefit.
Shingles: Best Results Within 72 Hours
For shingles (herpes zoster), Valtrex is taken three times daily for seven days. The medication has been shown to decrease both the duration of the shingles rash and the severity of pain that accompanies it. Compared to acyclovir, valacyclovir may be slightly more effective at reducing pain severity and shortening the duration of postherpetic neuralgia, the lingering nerve pain that can persist for months after the rash clears.
There’s a critical caveat: these benefits have only been demonstrated in patients who started antiviral treatment within 72 hours of the rash appearing. After that window closes, the evidence for meaningful benefit drops off. If you suspect shingles, getting to a doctor within the first three days matters more than almost any other factor in your outcome.
How Timing Shapes Effectiveness
Across every condition Valtrex treats, the same pattern holds: earlier treatment produces better results. For genital herpes outbreaks, the window is within one day. For shingles, it’s within 72 hours. For cold sores, it’s at the very first tingle. The drug works by blocking viral replication, so it’s most powerful when the virus is actively multiplying in the early stages of an outbreak. Once the infection has progressed and damage is done to the skin or nerve cells, there’s less for the drug to prevent.
This is why many people with frequent herpes outbreaks opt for daily suppressive therapy instead of episodic treatment. Rather than racing to catch each outbreak early enough, the medication is already circulating at effective levels when the virus tries to reactivate.
What Valtrex Does Not Do
Valtrex does not cure herpes. The virus remains dormant in nerve cells between outbreaks, and no currently available medication can eliminate it. What Valtrex does is suppress viral activity, reducing how often outbreaks occur, how severe they are, and how long they last.
It also does not completely eliminate transmission risk. Daily suppressive therapy reduces the chance of passing genital herpes to a partner, but it does not bring that risk to zero. Condom use alongside suppressive therapy provides a more substantial reduction in transmission than either strategy alone.
For cold sores specifically, it’s worth noting that the one-day treatment course is designed to treat an active outbreak. Valtrex is not FDA-approved for daily suppressive therapy to prevent cold sores in the general population, though some doctors prescribe it off-label for people with very frequent oral herpes recurrences.
Long-Term Use and Safety
Valtrex has been used for daily suppressive therapy for years at a time in clinical practice, and it has a well-established safety profile. Most people tolerate it without significant side effects. The most common complaints are headache and nausea, which tend to be mild. Resistance to the drug remains rare in people with healthy immune systems, though it can be a concern for immunocompromised patients who take antivirals over very long periods.
For people with kidney problems, dose adjustments are necessary because the drug is cleared through the kidneys. Your prescriber will typically check kidney function if you’re starting long-term therapy.